Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 13 Feb 2026 for Anaptysbio, INC, €250k. Read the official filing
Filing timeline
BuySaleEric J. Loumeau
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Eric J. Loumeau: trading record in brief
Eric J. Loumeau, listed as chief executive, appears in our data through filings on Anaptysbio, Inc shares, published by SEC (Form 4). We count 28 filings; the first trade dates from 4 November 2021 and the latest from 11 February 2026.
Sales make up the whole of the open-market record (9 sales, €1.1M). Other entries cover 3 share grants and 16 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
On 13 February 2026 came the latest disclosure, an option exercise for €250k in Anaptysbio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric J. Loumeau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
10,000 shares@ US$29.7013.5% of flowCommon StockSEC:0001239648-26-000007:0
5,888 sharesCommon StockSEC:0001239648-26-000006:0
5,545 sharesCommon StockSEC:0001239648-26-000004:0
2,983 shares@ US$43.267.3% of flowCommon StockSEC:0001239648-26-000002:1
7,287 sharesCommon StockSEC:0001239648-26-000002:0
10,000 shares@ US$14.027.9% of flowCommon StockSEC:0001239648-25-000006:0
10,000 shares@ US$51.0028.7% of flowCommon StockSEC:0001239648-25-000006:1
5,000 shares@ US$14.023.7% of flowCommon StockSEC:0001239648-25-000005:0
5,000 shares@ US$14.023.9% of flowCommon StockSEC:0001239648-25-000004:0
2,994 shares@ US$14.602.8% of flowCommon StockSEC:0001415889-25-001042:1
2,217 shares@ US$15.302.2% of flowCommon StockSEC:0001415889-25-001042:3
7,288 sharesCommon StockSEC:0001415889-25-001042:0
5,545 sharesCommon StockSEC:0001415889-25-001042:2
2,220 shares@ US$38.935.1% of flowCommon StockSEC:0001415889-24-023551:1
5,000 shares@ US$14.024.2% of flowCommon StockSEC:0001415889-24-023551:2
6,500 shares@ US$40.1315.4% of flowCommon StockSEC:0001415889-24-023551:3
3,780 shares@ US$38.41038.6% of flowCommon StockSEC:0001415889-24-023551:4
6,000 shares0Common StockSEC:0001415889-24-023551:0
5,000 shares@ US$14.024.3% of flowCommon StockSEC:0001415889-24-004666:0
2,305 shares@ US$21.813.0% of flowCommon StockSEC:0001209191-24-001279:1
5,545 shares0Common StockSEC:0001209191-24-001279:0
882 shares@ US$14.190.8% of flowCommon StockSEC:0001209191-23-056638:0
6,000 sharesCommon StockSEC:0001209191-23-049809:0
523 shares@ US$25.000.8% of flowCommon StockSEC:0001209191-22-045061:0
2,500 shares@ US$14.021.8% of flowCommon StockSEC:0001209191-22-036020:0
25 of 28 declarations
